ENTRY       D03305                      Drug
NAME        Interferon alfa (NAMALWA) (JP18);
            Interferon alfa (BALL-1) (JAN);
            Interferon alfa (INN);
            OIF (TN)
CLASS       Immunological agent
             DG01752  Interferone
REMARK      Therapeutic category: 6399
            ATC code: L03AB01
            Chemical structure group: DG01750
            Product (DG01750): D02745<US> D03305<JP>
EFFICACY    Antineoplastic, Antiviral, Biological response modifier
TARGET      IFNAR1 [HSA:3454] [KO:K05130]
            IFNAR2 [HSA:3455] [KO:K05131]
  PATHWAY   hsa04060(3454+3455)  Cytokine-cytokine receptor interaction
            hsa04620(3454+3455)  Toll-like receptor signaling pathway
            hsa04630(3454+3455)  JAK-STAT signaling pathway
            hsa04650(3454+3455)  Natural killer cell mediated cytotoxicity
            hsa05160(3454+3455)  Hepatitis C
            hsa05161(3454)  Hepatitis B
            hsa05162(3454+3455)  Measles
            hsa05200(3454+3455)  Pathways in cancer
INTERACTION  
STR_MAP     map07044  Antiviral agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L03 IMMUNOSTIMULANTS
               L03A IMMUNOSTIMULANTS
                L03AB Interferons
                 L03AB01 Interferon alfa natural
                  D03305  Interferon alfa (NAMALWA) (JP18) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               639  Miscellaneous
                6399  Others
                 D03305  Interferon alfa (NAMALWA) (JP18); Interferon alfa (BALL-1) (JAN); Interferon alfa (INN)
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01750  Interferon alpha
                D03305  Interferon alfa (NAMALWA)
            Drug classes [BR:br08332]
             Immunological agent
              DG01752  Interferone
               D03305  Interferon alfa (NAMALWA)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interferon receptors
                IFNAR1
                 D03305  Interferon alfa (NAMALWA) (JP18) &lt;JP&gt;
                IFNAR2
                 D03305  Interferon alfa (NAMALWA) (JP18) &lt;JP&gt;
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Interferon
                D03305  Interferon alfa (NAMALWA) (JP18) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D03305  Interferon alfa (NAMALWA)
              D03305  Interferon alfa (NAMALWA) injection
            Drug groups [BR:br08330]
             Immunological agent
              DG01752  Interferone
               DG01750  Interferon alpha
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Entry, fusion or uncoating inhibitor
               Interferon
                DG01750  Interferon alpha
DBLINKS     CAS: 74899-72-2
            PubChem: 17397456
///
